Baxter Pharmaceuticals India has announced the inauguration of a global Pharmaceuticals R&D Centre in Ahmedabad. The centre will help further the company's mission of saving and sustaining lives by accelerating innovation in the generic and differentiated injectable pharmaceuticals space.

The R&D Centre was inaugurated by Alok Sonig, President, Pharmaceuticals, Baxter International Inc. He was accompanied by Dr.Mahesh Chaubal, Vice President, Pharmaceuticals R&D, Baxter International Inc. and Dr Sanju Dhawan, Director of R&D, Baxter Pharmaceuticals India in Ahmedabad.  

The 20,500-square-foot, state-of-the-art R&D Centre features an array of sophisticated equipment and research labs that will focus on pharmaceutical product development and capabilities in therapeutic areas such as critical care, analgesic, renal, cardiovascular anesthesia, anti-infective and antipyretic. It will support Baxter's global manufacturing facilities, including those in Ahmedabad, Germany, Ireland, Italy, and the United States, among others.

This Pharmaceuticals R&D Centre is part of Baxter’s network of more than 25 global R&D centers, including 4 in the APAC region. The existing team of scientists, pharmacists, microbiologists, and analysts at the Pharmaceuticals R&D Centre have already contributed to the launch of several Baxter products globally.